China Focus: New policies set to ease burden for China's cancer patients

    Source: Xinhua| 2018-04-14 17:08:53|Editor: Yurou
    Video PlayerClose

    BEIJING, April 14 (Xinhua) -- A series of new policies on anticancer drugs in China will give hope to the country's cancer patients.

    According to the statement released after an executive meeting of the State Council on Thursday, from May 1, import tariffs on all common drugs including cancer drugs, cancer alkaloid-based drugs, and imported traditional Chinese medicine will be exempted.

    Also, value added tax in the production and import of drugs will drop by a large margin, which experts believe will be more effective in easing the economic burden of patients.

    With various measures taken into consideration, it is estimated that the policies will lower the drug prices by at least 20 percent, said Shi Luwen, director of the international research center on medicine management at Peking University.

    The measures will significantly enhance the availability and inclusiveness of the drugs, reduce the burden of patients' families, and will help prevent poverty caused by illness, he said.

    Statistics indicate that many cancer patients in China have been struggling to acquire cheap, quality medicine.

    According to the national cancer institute, the market for antineoplastic drugs in China exceeds 120 billion yuan (about 19.1 billion U.S. dollars). However, they are usually too expensive for working class families.

    "We are speeding up in making high-quality generic drugs available in the market, but most of the targeted anticancer drugs were still imported," said Liu Lihong, a doctor at the Beijing Chaoyang Hospital.

    Chen Wenming, another doctor at the hospital, said that despite social insurance, patients in Beijing still have to pay 20 percent of the total price of the drugs. The percentage is even higher in less developed areas.

    For this, the State Council put forward a solution at the meeting, asking for the timely inclusion of imported new drugs in the range of medical insurance, especially urgent cancer drugs.

    In addition, the import procedures of new medicine will be streamlined, as importing enterprises will take charge of the examination of the drugs, instead of compulsory examination by authorities.

    "It will make it easier for patients to access the drugs in terms of timing," said Shi Luwen. "It also adds to the enterprises' responsibilities to ensure the quality and safety of the drugs, while saving their time."

    As for the long term, experts are expecting higher capabilities of medical institutions on the grassroots level, and the balance of the share of drugs in different areas, so that urgent medicine including anticancer drugs can more efficiently and accurately benefit the people.

    "More measures will soon be implemented to make sure those in urgent need of medicine can get sufficient, quality and cheaper drugs in time," the National Health Commission said.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001371109981
    主站蜘蛛池模板: 一本色道无码道dvd在线观看| 亚洲欧美日韩久久精品第一区| jizzjlzzjlzz性欧美| 成人国产一区二区三区精品| 亚洲国产一成人久久精品| 精品影片在线观看的网站| 国产欧美日韩综合精品一区二区 | 国产成人免费电影| 99色在线观看| 搞av.com| 亚洲bt欧美bt精品| 激情小说在线视频| 四虎影院wwww| 国产妇乱子伦视频免费| 国内精品一区二区三区在线观看| 中文字幕不卡在线观看| 明星ai换脸高清一区| 亚洲欧美日韩国产精品网| 精品四虎免费观看国产高清午夜 | 国产激情精品一区二区三区| a级特黄的片子| 成年女人免费v片| 久久精品国产一区二区三区不卡| 欧美色图亚洲自拍| 免费高清在线观看a网站| 试看120秒做受小视频免费| 国产精品久久久久鬼色| 9久热精品免费观看视频| 成人影片在线免费观看 | 亚洲av无码乱码在线观看| 浪潮AV色综合久久天堂| 又粗又硬又大又爽免费视频播放| 黄色网站免费在线观看| 国产精品成熟老女人视频| 99福利视频导航| 尤物在线观看精品国产福利片| 久久国产精品女| 欧美XXXX黑人又粗又长精品| 亚洲精品中文字幕乱码影院| 福利免费在线观看| 又大又硬又爽免费视频|